Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Takung Art Co., Ltd | Financial_Report.xls |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
Amendment No. 1
(Mark One)
| X | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2013
OR
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 333-176329
| CARDIGANT MEDICAL, INC. |
| (Exact name of Registrant as Specified in Its Charter) |
| DELAWARE |
| 26-4731758 |
| (State or other jurisdiction of incorporation or organization) |
| (I.R.S. Employer Identification No.) |
|
|
|
|
| 1500 ROSECRANS AVENUE, ST 500, MANHATTAN BEACH, CALIFORNIA |
| 90266 |
| (Address of principal executive offices) |
| (Zip Code) |
Registrant’s telephone number, including area code: (310) 421-8654
Securities registered under Section 12(b) of the Act:
None
Securities registered under Section 12(g) of the Exchange Act:
Common Stock, par value $0.001 per share
None
Indicate by check mark if the registrant is a well-known seasoned
issuer, as defined in Rule 405 of the Securities Act. Yes _ No X
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes X No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes X No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one).
| Large Accelerated Filer o | Accelerated Filer o | Non-Accelerated Filer o | Smaller reporting company X |
|
|
| (Do not check if a smaller reporting company) |
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes oNo X
The aggregate market value of the voting and non-voting common equity held by non-affiliates as of June 30, 2013, computed by reference to the price at which the common equity was last sold, or as of the last business day of the registrant's most recently completed second fiscal quarter, was approximately $401,142 based upon an estimated per share value of $0.525 at June 30, 2013. For purposes of this computation, it is assumed that the shares beneficially held by directors and officers of the registrant would be deemed to be stock held by affiliates.
As of March 1, 2014, there were 23,235,510 shares of the registrant’s common stock outstanding.
______________________________________________________________________________________________________________________________________________________________________
The Registrant is filing this Amendment No. 1 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013 (“Form 10-K”) solely to include the required XBRL files. While the XBRL files were included in the original filing, they were excluded from the Edgar system due to the Official Registrant Name being listed within the XBRL files as Cardigant Medical, Inc. versus the SEC recognized Official Registrant Name of Cardigant Medical Inc. without the comma.
Except for the items mentioned above, this Amendment No. 1 does not amend the Registrant’s previously filed Form 10-K.
_____________________________________________________________________________________________________________________________________________________________________
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
| CARDIGANT MEDICAL, INC. | |
|
| By: /s/ Jerett A. Creed | |
| Dated: April 08, 2014 |
| Jerett A. Creed |
|
|
| Chief Executive Officer |
| By: /s/ Jerett A. Creed | ||
| Dated: April 08, 2014 | Jerett A. Creed | |
| Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | ||